Balyasny Asset Management LLC Vbi Vaccines Inc Transaction History

Balyasny Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $14,349 - $39,353	21,742 New	21,742 $18,000
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $1.93 Million - $2.81 Million	-874,043 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $2.45 Million - $3.25 Million	874,043 New	874,043 $2.72 Million

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.